Psoriasis Completed Phase 4 Trials for Infliximab (DB00065)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00261976A Long-term Safety Study of Infliximab (Remicade)
NCT00760669An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
NCT00462072Centocor Microarray Study of PatientsTreatment
NCT00686595A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133)Treatment